Author Reply to Letter to the Editor: In Response to: Comment on Sutton et al.'s "Allopurinol and the Risk of Diabetic Macular Edema among US Veterans with Type 2 Diabetes"

被引：3

作者：

Sutton, S. Scott ^{[1
,2
]}

Magagnoli, Joseph ^{[1
,2
,5
]}

Cummings, Tammy H. H. ^{[1
,2
]}

Hardin, James W. W. ^{[3
]}

Ambati, Jayakrishna ^{[4
]}

机构：

[1] Columbia VA Hlth Care Syst, Dorn Res Inst, Columbia, SC USA

[2] Univ South Carolina, Coll Pharm, Dept Clin Pharm & Outcomes Sci, Columbia, SC USA

[3] Univ South Carolina, Dept Epidemiol & Biostat, Columbia, SC USA

[4] Univ Virginia, Dept Ophthalmol, Charlottesville, VA USA

[5] Univ South Carolina Coll Pharm, Clin Pharm & Outcomes Sci, 715 Sumter St 311B, Columbia, SC 29208 USA

来源：

OCULAR IMMUNOLOGY AND INFLAMMATION | 2024年 / 32卷 / 07期

关键词：

D O I：

10.1080/09273948.2023.2219326

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

引用

页码：1454 / 1456

页数：3

共 50 条

[1] Comment on Sutton et al.'s "Allopurinol and the Risk of Diabetic Macular Edema Among US Veterans with Type 2 Diabetes"
Lai, Shih-Wei
[J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2024, 32 (07) : 1509 - 1509
[2] Allopurinol and the Risk of Diabetic Macular Edema among US Veterans with Type 2 Diabetes
Sutton, S. Scott
Magagnoli, Joseph
Cummings, Tammy H.
Hardin, James W.
Ambati, Jayakrishna
[J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2024, 32 (06) : 969 - 975
[3] Authors Reply to Letter to the Editor- In Response to: Comment on Durrani et al.'s "Adalimumab for Ocular Inflammation"
Durrani, Khayyam
Kempen, John H.
Foster, C. Stephen
[J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2019, 27 (01) : 71 - 71
[4] Response to Comment on Allen et al. Thirty-Year Time Trends in Diabetic Retinopathy and Macular Edema in Youth With Type 1 Diabetes.
Allen, Digby W.
Craig, Maria E.
Donaghue, Kim C.
[J]. DIABETES CARE, 2022, 45 (12) : E185 - E186
[5] Reply to the Comment by Ilhan et al. on Our Paper Entitled 'Effect of Macular Ischemia on Intravitreal Ranibizumab Treatment for Diabetic Macular Edema'
Chatziralli, Irini
Douvali, Maria
Theodossiadis, Panagiotis
Rouvas, Alexandros A.
[J]. OPHTHALMOLOGICA, 2015, 233 (02) : 116 - 116
[6] Reply to Letter to the Editor: Prevalence and Incidence of Huntington's Disease Comment on Medina et al. (2022)
Pringsheim, Tamara
[J]. MOVEMENT DISORDERS, 2023, 38 (08) : 1572 - 1573
[7] Comment on Allen et al. Thirty-Year Time Trends in Diabetic Retinopathy and Macular Edema in Youth With Type 1 Diabetes.
Xu, Manhong
Li, Xiaorong
[J]. DIABETES CARE, 2022, 45 (12) : E184 - E184
[8] Author's response to Letter to the Editor by Kauffman et al. published in JNI 212/1-2, June 2009
Vecsei, Laszlo
Losonczi, Erika
Bencsik, Krisztina
Rajda, Cecilia
[J]. JOURNAL OF NEUROIMMUNOLOGY, 2009, 217 (1-2) : 102 - 102
[9] Comment on the Article by Dutra Medeiros et al. Entitled 'Dexamethasone Intravitreal Implant for Treatment of Patients with Persistent Diabetic Macular Edema' Reply
Dutra Medeiros, Marco
Navarro, Rafael
Mateo, Carlos
Garcia-Arumi, Jose
Corcostegui, Borja
[J]. OPHTHALMOLOGICA, 2015, 233 (02) : 118 - 118
[10] Reply to Chand et al. regarding letter to the Editor regarding the article: 'Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: A cohort analysis (Ghoshal et al.)'
Ghoshal, Samit
[J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (05) : 1541 - 1541

← 1 2 3 4 5 →